Galectin Therapeutics shares owned by Nine Masts Capital
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Nine Masts Capital
from 13F filings
Historical chart of Nine Masts Capital investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Nine Masts Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $54k | 19k | 2.79 |